OBJECTIVE: To determine whether integrating antiretroviral therapy (ART) into antenatal care (ANC) and maternal and child health (MCH) clinics could improve programmatic and patient outcomes. METHODS: The authors systematically searched PubMed, Embase, African Index Medicus and LiLACS for randomized controlled trials, prospective cohort studies, or retrospective cohort studies comparing outcomes in ANC or MCH clinics that had and had not integrated ART. The outcomes of interest were ART coverage, ART enrolment, ART retention, mortality and transmission of human immunodeficiency virus (HIV). FINDINGS: Four studies met the inclusion criteria. All were conducted in ANC clinics. Increased enrolment of pregnant women in ART was observed in ANC clinics that had integrated ART (relative risk, RR: 2.09; 95% confidence interval, CI; 1.78-2.46; I(2): 15%). Increased ART coverage was also noted in such clinics (RR: 1.37; 95% CI: 1.05-1.79; I(2): 83%). Sensitivity analyses revealed a trend for the national prevalence of HIV infection to explain the heterogeneity in the size of the effect of ART integration on ART coverage (P = 0.13). Retention in ART was similar in ANC clinics with and without ART integration. CONCLUSION: Although few data were available, ART integration in ANC clinics appears to lead to higher rates of ART enrolment and ART coverage. Rates of retention in ART remain similar to those observed in referral-based models.
OBJECTIVE: To determine whether integrating antiretroviral therapy (ART) into antenatal care (ANC) and maternal and child health (MCH) clinics could improve programmatic and patient outcomes. METHODS: The authors systematically searched PubMed, Embase, African Index Medicus and LiLACS for randomized controlled trials, prospective cohort studies, or retrospective cohort studies comparing outcomes in ANC or MCH clinics that had and had not integrated ART. The outcomes of interest were ART coverage, ART enrolment, ART retention, mortality and transmission of human immunodeficiency virus (HIV). FINDINGS: Four studies met the inclusion criteria. All were conducted in ANC clinics. Increased enrolment of pregnant women in ART was observed in ANC clinics that had integrated ART (relative risk, RR: 2.09; 95% confidence interval, CI; 1.78-2.46; I(2): 15%). Increased ART coverage was also noted in such clinics (RR: 1.37; 95% CI: 1.05-1.79; I(2): 83%). Sensitivity analyses revealed a trend for the national prevalence of HIV infection to explain the heterogeneity in the size of the effect of ART integration on ART coverage (P = 0.13). Retention in ART was similar in ANC clinics with and without ART integration. CONCLUSION: Although few data were available, ART integration in ANC clinics appears to lead to higher rates of ART enrolment and ART coverage. Rates of retention in ART remain similar to those observed in referral-based models.
Authors: L D Bwirire; M Fitzgerald; R Zachariah; V Chikafa; M Massaquoi; M Moens; K Kamoto; E J Schouten Journal: Trans R Soc Trop Med Hyg Date: 2008-05-16 Impact factor: 2.184
Authors: J Ditekemena; R Matendo; O Koole; R Colebunders; M Kashamuka; A Tshefu; N Kilese; D Nanlele; R Ryder Journal: Int J STD AIDS Date: 2011-03 Impact factor: 1.359
Authors: Lena E Winestone; Elizabeth A Bukusi; Craig R Cohen; Daniel Kwaro; Nicole C Schmidt; Janet M Turan Journal: Glob Public Health Date: 2011-11-01
Authors: Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey Journal: AIDS Date: 2008-05-11 Impact factor: 4.177
Authors: Jessica H Oyugi; Jayne Byakika-Tusiime; Kathleen Ragland; Oliver Laeyendecker; Roy Mugerwa; Cissy Kityo; Peter Mugyenyi; Thomas C Quinn; David R Bangsberg Journal: AIDS Date: 2007-05-11 Impact factor: 4.177
Authors: Jennifer Y Chen; Anthony C Ogwu; Petr Svab; Shahin Lockman; Howard J Moffat; Tendani Gaolathe; Shana Moilwa; Ketil Størdal; Scott Dryden-Peterson; Claire Moffat; Joseph Makhema; M Essex; Roger L Shapiro Journal: J Acquir Immune Defic Syndr Date: 2010-05-01 Impact factor: 3.731
Authors: Jennifer A Pellowski; Alison Z Weber; Tamsin K Phillips; Kirsty Brittain; Allison Zerbe; Elaine J Abrams; Landon Myer Journal: AIDS Care Date: 2019-08-27
Authors: Alison S Rustagi; Sarah Gimbel; Ruth Nduati; Maria de Fatima Cuembelo; Judith N Wasserheit; Carey Farquhar; Stephen Gloyd; Kenneth Sherr Journal: Int J STD AIDS Date: 2016-09-02 Impact factor: 1.359
Authors: Surbhi Modi; Tegan Callahan; Jessica Rodrigues; Mwikemo D Kajoka; Helen M Dale; Judite O Langa; Marilena Urso; Matsepeli I Nchephe; Helene Bongdene; Sostena Romano; Laura N Broyles Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731
Authors: David R Martinez; Nathan Vandergrift; Ayooluwa O Douglas; Erin McGuire; John Bainbridge; Nathan I Nicely; David C Montefiori; Georgia D Tomaras; Genevieve G Fouda; Sallie R Permar Journal: J Virol Date: 2017-04-13 Impact factor: 5.103
Authors: Jillian Pintye; Dvora L Joseph Davey; Anjuli D Wagner; Grace John-Stewart; Rachel Baggaley; Linda-Gail Bekker; Connie Celum; Benjamin H Chi; Thomas J Coates; Allison K Groves; Jessica E Haberer; Renee Heffron; John Kinuthia; Lynn T Matthews; James A McIntyre; Dhayendre Moodley; Lynne M Mofenson; Nelly Mugo; Andrew Mujugira; Landon Myer; Steven Shoptaw; Lynda Stranix-Chibanda; Jared M Baeten Journal: Lancet HIV Date: 2020-08 Impact factor: 12.767
Authors: Jillian Pintye; John Kinuthia; D Allen Roberts; Anjuli D Wagner; Kenneth Mugwanya; Felix Abuna; Harison Lagat; George Owiti; Carol E Levin; Ruanne V Barnabas; Jared M Baeten; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2018-12-15 Impact factor: 3.731